Congressman Brian Fitzpatrick

Congressman Brian Fitzpatrick | Our Independent Voice
Mobile Menu - OpenMobile Menu - Closed

Health

Fitzpatrick Urges Participation in Prescription Drug Takeback Program

LANGHORNE, PA - Congressman Brian Fitzpatrick (PA-8) is urging Bucks County residents to help safely dispose of unused and expired prescription medicines to help keep them out of the wrong hands. On Saturday, April 29 from 10am -2pm individuals can drop off items at locations around the county – a complete list can be found at www.fitzpatrick.house.gov/prescription-drop-boxes  

Brian Fitzpatrick bill targets smuggling of deadly opioid fentanyl

Fentanyl, a prescription painkiller that is among the most popular and yet deadliest synthetic opioids sold on the illicit market, has been targeted by new legislation introduced Tuesday by Congressman Brian Fitzpatrick, R-8, Middletown. 

Co-sponsored by Massachusetts Rep. Niki Tsongas, a Democrat, the International Narcotics Trafficking Emergency Response by Detecting Incoming Contraband with Technology (INTERDICT) Act will provide more funding and equipment to U.S. Customs and Border Patrol.

Fitzpatrick, Tsongas Bill Targets Synthetic Drug 50x Stronger Than Heroin

WASHINGTON, D.C. – Congressman Brian Fitzpatrick (R-PA) and Congresswoman Niki Tsongas (D-MA) have introduced the International Narcotics Trafficking Emergency Response by Detecting Incoming Contraband with Technology (INTERDICT) Act, a bipartisan bill to combat the opioid epidemic. The legislation would provide U.S. Customs and Border Protection (CBP) the latest in chemical screening devices and scientific support to detect and intercept fentanyl and other synthetic opioids.

Bill would give treatment options to terminally ill

Almost 13 years after he was given a life-changing medical diagnosis, state Rep. Robert Godshall is still trying to turn his unfortunate circumstances into a lifeline for other Pennsylvanians.

The Montgomery County Republican, a bone marrow cancer survivor, is pushing legislation in the General Assembly that would allow terminally ill patients to access medical treatments or products not yet approved by the U.S. Food and Drug Administration.

Pages